MediPal Holdings Corporation
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drug… Read more
MediPal Holdings Corporation (MEPDF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2023: 0.042x
Based on the latest financial reports, MediPal Holdings Corporation (MEPDF) has a cash flow conversion efficiency ratio of 0.042x as of December 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($29.67 Billion) by net assets ($712.57 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
MediPal Holdings Corporation - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how MediPal Holdings Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
MediPal Holdings Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MediPal Holdings Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Endeavour Silver Corp.
NYSE:EXK
|
0.053x |
|
China Longyuan Power Group Corporation Limited
F:6WX
|
-0.023x |
|
Integer Holdings Corp
NYSE:ITGR
|
0.038x |
|
Vallourec S.A
PINK:VLOUF
|
0.130x |
|
Genting Berhad
PINK:GEBHY
|
0.028x |
|
Miami International Holdings, Inc.
NYSE:MIAX
|
0.066x |
|
Vault Minerals Limited
F:RKM0
|
N/A |
|
Karur Vysya Bank Limited
NSE:KARURVYSYA
|
0.013x |
Annual Cash Flow Conversion Efficiency for MediPal Holdings Corporation (2005–2025)
The table below shows the annual cash flow conversion efficiency of MediPal Holdings Corporation from 2005 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | $757.95 Billion | $60.56 Billion | 0.080x | -4.83% |
| 2024-03-31 | $736.61 Billion | $61.84 Billion | 0.084x | +257.77% |
| 2023-03-31 | $688.05 Billion | $16.15 Billion | 0.023x | -75.12% |
| 2022-03-31 | $649.09 Billion | $61.22 Billion | 0.094x | +74.93% |
| 2021-03-31 | $638.93 Billion | $34.45 Billion | 0.054x | -42.46% |
| 2020-03-31 | $607.42 Billion | $56.92 Billion | 0.094x | -12.81% |
| 2019-03-31 | $592.85 Billion | $63.72 Billion | 0.107x | -3.17% |
| 2018-03-31 | $572.65 Billion | $63.56 Billion | 0.111x | +20.62% |
| 2017-03-31 | $521.16 Billion | $47.95 Billion | 0.092x | +104.38% |
| 2016-03-31 | $488.33 Billion | $21.98 Billion | 0.045x | -74.40% |
| 2015-03-31 | $457.60 Billion | $80.47 Billion | 0.176x | +99616.75% |
| 2014-03-31 | $407.48 Billion | $-72.00 Million | 0.000x | -100.11% |
| 2013-03-31 | $381.89 Billion | $61.77 Billion | 0.162x | +2982.98% |
| 2012-03-31 | $354.34 Billion | $-1.99 Billion | -0.006x | -103.87% |
| 2011-03-31 | $340.98 Billion | $49.47 Billion | 0.145x | +243.23% |
| 2010-03-31 | $330.99 Billion | $13.99 Billion | 0.042x | -46.73% |
| 2009-03-31 | $294.50 Billion | $23.37 Billion | 0.079x | -3.74% |
| 2008-03-31 | $290.69 Billion | $23.96 Billion | 0.082x | +8.52% |
| 2007-03-31 | $261.11 Billion | $19.84 Billion | 0.076x | -55.94% |
| 2006-03-31 | $242.41 Billion | $41.80 Billion | 0.172x | +10.20% |
| 2005-03-31 | $168.10 Billion | $26.30 Billion | 0.156x | -- |